Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.

It is suggested that in human breast cancer, S100A4 exerts some of its effects through angiogenesis, and that osteopontin is dependent on ERalpha for its expression.